EITR BIOLOGICS, INC.
Federal contract awards won by EITR BIOLOGICS, INC. (UEI HX49LZLY32G5), 2022–2026 — public record from USAspending.
Showing awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
10
awards
$37,451,521
total value
2
agencies
Agencies buying from EITR BIOLOGICS, INC.
What EITR BIOLOGICS, INC. sells
Awards
NOVEL BISPECIFIC BROAD SPECTRUM NANOBODY
Department of Defense · $269,999 · Apr 1, 2026
NOVEL BISPECIFIC BROAD SPECTRUM NANOBODY
Department of Defense · $926,999 · Feb 1, 2026
NOVEL NANOTHERAPEUTICS
Department of Defense · $300,000 · Jul 1, 2025
NOVEL NANOTHERAPEUTICS
Department of Defense · $1,864,756 · Sep 20, 2024
DEVELOP A NOVEL ODIN THERAPEUTIC MEDICAL COUNTERMEASURE CAPABLE OF PROTECTING AGAINST PNEUMONIC UNENCAPSULATED Y. PESTIS.
Department of Defense · $499,896 · Jul 1, 2024
SORTING PERIPHERAL BLOOD MONONUCLEAR CELLS FROM LASSA FEVER VIRUS SURVIVORS TO DISCOVER AND PRODUCE MONOCLONAL ANTIBODIES FOR ASSESSMENT IN IN VITRO AND IN VIVO ASSAYS
Department of Defense · $729,721 · Dec 6, 2023
THE DEVELOPMENT OF A MULTIMODAL ANTIBODY PLATFORM TO EXTEND THE WINDOW OF IMMUNOTHERAPEUTIC INTERVENTION. THE OVERALL OBJECTIVE OF THE WORK OUTLINED IN THIS CONTRACT IS TO CRITICALLY EVALUATE THE UTILITY OF THE VHH AS A PLATFORM MCM TECHNOLOGY FOR VI
Department of Health and Human Services · $26,614,177 · Sep 22, 2023
NOVEL NANOTHERAPEUTIC APPROACHES PENETRATING THE OUTER LAYERS OF THE BACTERIUM AND TARGETING OUTER MEMBRANE PROTEINS FOR THE TREATMENT OF PNEUMONIC PLAGUE FOR ASSESSMENT IN IN VITRO AND IN VIVO ASSAYS
Department of Defense · $750,000 · Sep 1, 2023
NOVEL NANOTHERAPEUTICS FOR COMBATTING PNEUMONIC PLAGUE
Department of Defense · $4,390,206 · Aug 15, 2023
NOVEL CELL SORTING
Department of Defense · $1,105,767 · Nov 28, 2022
Researching this competitor? BidCatch doesn't just show you what they won — it sends you the open bids in your trade every morning, before they're awarded. Free for 14 days, then $49.99/month.
Search open bids